SPRB · Spruce Biosciences Inc. Common Stock
View on chartInsiders & Stakes
| Novo Holdings A/S 10% Owner | ▼ Sell | Open Market | 2,550,000 Shares held | 3/21/2024 | View profile |
| O'Donnell Niall Director | ▲ Buy | Open Market | 1,326,305 Shares held | 2/16/2023 | View profile |
| Ralph William Charlton III Chief Medical Officer | ▼ Sell | Tax Withholding | 161,339 Shares held | 12/16/2024 | View profile |
| Javier B. Szwarcberg Chief Executive Officer | ▲ Buy | Grant | 19,270 Shares held | 6/30/2026 | View profile |
| Samir M. Gharib President & CFO | ▼ Sell | Tax Withholding | 8,263 Shares held | 12/15/2025 | View profile |
| Douglas Kirk Ways Interim Chief Medical Officer | ▲ Buy | Option Exercise | 1,250 Shares held | 12/11/2025 | View profile |
| Parkman Healthcare Partners LLC 10% Owner | ▼ Sell | Open Market | 1,050 Shares held | 10/6/2025 | View profile |
Transaction History
| Javier B. Szwarcberg | ▲ Buy | Grant | 266 | $1K | 6/30/2026 |
| Javier B. Szwarcberg | ▲ Buy | Grant | 4,690 | $21K | 12/31/2025 |
| Javier B. Szwarcberg | ▲ Buy | Option Exercise | 1,196 | $0 | 12/15/2025 |
| Samir M. Gharib | ▼ Sell | Tax Withholding | 178 | $14K | 12/15/2025 |
| Javier B. Szwarcberg | ▲ Buy | Option Exercise | 1,480 | $0 | 12/15/2025 |
| Samir M. Gharib | ▲ Buy | Option Exercise | 513 | $0 | 12/15/2025 |
| Javier B. Szwarcberg | ▼ Sell | Tax Withholding | 608 | $49K | 12/15/2025 |
| Samir M. Gharib | ▼ Sell | Tax Withholding | 184 | $15K | 12/15/2025 |
| Javier B. Szwarcberg | ▼ Sell | Tax Withholding | 752 | $61K | 12/15/2025 |
| Samir M. Gharib | ▲ Buy | Option Exercise | 496 | $0 | 12/15/2025 |
| Douglas Kirk Ways | ▲ Buy | Option Exercise | 1,250 | $0 | 12/11/2025 |
| Samir M. Gharib | ▲ Buy | Option Exercise | 1,900 | $0 | 12/11/2025 |
| Samir M. Gharib | ▼ Sell | Tax Withholding | 680 | $60K | 12/11/2025 |
| Javier B. Szwarcberg | ▲ Buy | Option Exercise | 4,950 | $0 | 12/11/2025 |
| Javier B. Szwarcberg | ▼ Sell | Tax Withholding | 2,194 | $194K | 12/11/2025 |
| Samir M. Gharib | ▲ Buy | Option Exercise | 514 | $0 | 12/10/2025 |
| Samir M. Gharib | ▼ Sell | Tax Withholding | 184 | $16K | 12/10/2025 |
| Javier B. Szwarcberg | ▲ Buy | Option Exercise | 1,196 | $0 | 12/10/2025 |
| Javier B. Szwarcberg | ▼ Sell | Tax Withholding | 428 | $37K | 12/10/2025 |
| Samir M. Gharib | ▲ Buy | Option Exercise | 2,053 | $0 | 10/20/2025 |
| Samir M. Gharib | ▼ Sell | Tax Withholding | 661 | $98K | 10/20/2025 |
| Javier B. Szwarcberg | ▲ Buy | Option Exercise | 4,784 | $0 | 10/20/2025 |
| Javier B. Szwarcberg | ▼ Sell | Tax Withholding | 1,539 | $228K | 10/20/2025 |
| Parkman Healthcare Partners LLC | ▲ Buy | Open Market | 256 | $5K | 10/6/2025 |
| Parkman Healthcare Partners LLC | ▼ Sell | Open Market | 232 | $4K | 10/6/2025 |
| Parkman Healthcare Partners LLC | ▼ Sell | Open Market | 25 | $436 | 10/6/2025 |
| Parkman Healthcare Partners LLC | ▲ Buy | Open Market | 256 | $5K | 10/6/2025 |
| Parkman Healthcare Partners LLC | ▼ Sell | Open Market | 232 | $4K | 10/6/2025 |
| Parkman Healthcare Partners LLC | ▼ Sell | Open Market | 25 | $436 | 10/6/2025 |
| Samir M. Gharib | ▲ Buy | Option Exercise | 37,250 | $0 | 12/16/2024 |
| Javier B. Szwarcberg | ▼ Sell | Tax Withholding | 39,605 | $15K | 12/16/2024 |
| Ralph William Charlton III | ▲ Buy | Option Exercise | 26,600 | $0 | 12/16/2024 |
| Ralph William Charlton III | ▼ Sell | Tax Withholding | 9,491 | $4K | 12/16/2024 |
| Ralph William Charlton III | ▼ Sell | Tax Withholding | 11,329 | $4K | 12/16/2024 |
| Samir M. Gharib | ▲ Buy | Option Exercise | 38,500 | $0 | 12/16/2024 |
| Samir M. Gharib | ▼ Sell | Tax Withholding | 13,737 | $5K | 12/16/2024 |
| Samir M. Gharib | ▼ Sell | Tax Withholding | 13,291 | $5K | 12/16/2024 |
| Javier B. Szwarcberg | ▲ Buy | Option Exercise | 89,700 | $0 | 12/16/2024 |
| Javier B. Szwarcberg | ▼ Sell | Tax Withholding | 32,005 | $12K | 12/16/2024 |
| Javier B. Szwarcberg | ▲ Buy | Option Exercise | 111,000 | $0 | 12/16/2024 |
| Ralph William Charlton III | ▲ Buy | Option Exercise | 31,750 | $0 | 12/16/2024 |
| Ralph William Charlton III | ▲ Buy | Option Exercise | 106,400 | $0 | 12/10/2024 |
| Ralph William Charlton III | ▼ Sell | Tax Withholding | 37,964 | $20K | 12/10/2024 |
| Samir M. Gharib | ▲ Buy | Option Exercise | 154,000 | $0 | 12/10/2024 |
| Samir M. Gharib | ▼ Sell | Tax Withholding | 54,948 | $30K | 12/10/2024 |
| Javier B. Szwarcberg | ▲ Buy | Option Exercise | 358,800 | $0 | 12/10/2024 |
| Javier B. Szwarcberg | ▼ Sell | Tax Withholding | 128,020 | $69K | 12/10/2024 |
| Novo Holdings A/S | ▼ Sell | Open Market | 465,021 | $351K | 3/21/2024 |
| Novo Holdings A/S | ▼ Sell | Open Market | 359,979 | $264K | 3/20/2024 |
| Novo Holdings A/S | ▼ Sell | Open Market | 593,000 | $448K | 3/19/2024 |
| Novo Holdings A/S | ▼ Sell | Open Market | 842,020 | $647K | 3/18/2024 |
| Novo Holdings A/S | ▼ Sell | Open Market | 1,912,316 | $1.7M | 3/14/2024 |
| Samir M. Gharib | ▲ Buy | Grant | 11,255 | $11K | 12/29/2023 |
| Ralph William Charlton III | ▲ Buy | Grant | 9,361 | $9K | 12/29/2023 |
| Javier B. Szwarcberg | ▲ Buy | Option Exercise | 111,000 | $0 | 12/15/2023 |
| Javier B. Szwarcberg | ▼ Sell | Tax Withholding | 38,384 | $64K | 12/15/2023 |
| Ralph William Charlton III | ▲ Buy | Option Exercise | 31,750 | $0 | 12/15/2023 |
| Samir M. Gharib | ▼ Sell | Tax Withholding | 12,882 | $21K | 12/15/2023 |
| Ralph William Charlton III | ▼ Sell | Tax Withholding | 10,980 | $18K | 12/15/2023 |
| Samir M. Gharib | ▲ Buy | Option Exercise | 75,000 | $0 | 12/15/2023 |
| Samir M. Gharib | ▼ Sell | Tax Withholding | 23,213 | $39K | 12/15/2023 |
| Samir M. Gharib | ▲ Buy | Option Exercise | 37,250 | $0 | 12/15/2023 |
| Samir M. Gharib | ▲ Buy | Option Exercise | 75,000 | — | 6/30/2023 |
| Samir M. Gharib | ▼ Sell | Tax Withholding | 25,936 | $56K | 6/30/2023 |
| Samir M. Gharib | ▲ Buy | Grant | 10,484 | $10K | 6/30/2023 |
| Javier B. Szwarcberg | ▲ Buy | Grant | 20,000 | $20K | 6/30/2023 |
| Ralph William Charlton III | ▲ Buy | Grant | 12,378 | $12K | 6/30/2023 |
| O'Donnell Niall | ▲ Buy | Open Market | 630,400 | $2.0M | 2/16/2023 |
| Novo Holdings A/S | ▲ Buy | Open Market | 2,208,000 | $7.0M | 2/16/2023 |
| Samir M. Gharib | ▼ Sell | Tax Withholding | 15,293 | $18K | 1/3/2023 |
| Samir M. Gharib | ▲ Buy | Option Exercise | 37,500 | — | 1/3/2023 |
| Ralph William Charlton III | ▲ Buy | Grant | 12,864 | $12K | 12/30/2022 |
| Javier B. Szwarcberg | ▲ Buy | Grant | 14,705 | $14K | 12/30/2022 |
| Samir M. Gharib | ▲ Buy | Grant | 1 | $1 | 12/30/2022 |
| Samir M. Gharib | ▼ Sell | Tax Withholding | 12,968 | $23K | 6/30/2022 |
| Samir M. Gharib | ▲ Buy | Option Exercise | 37,500 | — | 6/30/2022 |
| Samir M. Gharib | ▲ Buy | Grant | 5,446 | $8K | 6/30/2022 |
| Samir M. Gharib | ▼ Sell | Other | 2,220 | $8K | 12/31/2021 |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
September 28, 2026
Citizens Maintains $144 Target for Spruce Biosciences
Citizens Capital Markets has reaffirmed a market‑outperform rating for Spruce Biosciences and kept its $144 price target. The target sits well above the current trading level and within the company’s 52‑week range, suggesting upside potential. Analysts average a target of $148, with a wide range from $104 to $230. The stock’s RSI of 37.6 and a support level at $48.43 indicate it is not in overbought territory.
Citizens Maintains $144 Target for Spruce Biosciences. Citizens Capital Markets has reaffirmed a market‑outperform rating for Spruce Biosciences and kept its $144 price target. The target sits well above the current trading level and within the company’s 52‑week range, suggesting upside potential. Analysts average a target of $148, with a wide range from $104 to $230. The stock’s RSI of 37.6 and a support level at $48.43 indicate it is not in overbought territory.